Skip to main content

Series A Biotechnology Companies

Explore 774 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
774
Total Funding
$1.6B
Avg Funding
$64.0M
Cities
20

Export 774 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$8.9M
raised

Leucid is progressing novel cart therapies that produce a better and more durable response.

Feb 2025
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$52.5M
raised

Trotana Therapeutics is a biotech company that focuses on the discovery and development of medicines targeting RNA-binding proteins.

Feb 2025
Series A

Founder Contacts

41,000+ verified contacts

New York, United States
$14.0M
raised

Nucleus is a new kind of genetic test designed to uncover your risks and help you have healthy kids.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Columbus, United States

Clarametyx Biosciences is a biotechnology company that develops immune-enabling biologic therapies.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$65.0M
raised

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Valencia, Spain
$50.0M
raised

Quibim is a radiomics company specializing in quantitative imaging of biomarkers and medical applications in precision medicine.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

$6.1M
raised

XFOREST Therapeutics is a biotech company focused on drug discovery using RNA structures.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Indianapolis, United States
$5.0M
raised

PinkDx is a biotechnology company.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Doylestown, United States

IVIEW Therapeutics is an ophthalmology drug development company that focuses on the treatment of viral conjunctivitis.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Atlanta, United States
$16.0M
raised

Micron Biomedical is a clinical-stage biopharmaceutical company on a rapid path to bring drugs and vaccines to market.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Burlingame, United States
$30.0M
raised

Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$41.0M
raised

Bioptimus is an AI company that offers a foundation model for biology to fuel breakthrough discoveries and accelerate.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$86.0M
raised

Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$120.0M
raised

Ouroboros Medicines is a biotechnology company specializes in immunology.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Tampa, United States
$5.8M
raised

Inflammx Therapeutics is a biotechnology startup company.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$62.0M
raised

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$32.9M
raised

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$180.0M
raised

Timberlyne Therapeutics is a biopharmaceutical company that develops therapies for autoimmune diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$411.0M
raised

Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Oxford, United Kingdom
$11.0M
raised

OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$200.0M
raised

Tenvie Therapeutics is a biotechnology company that transforms the treatment of neurological diseases through engineered small molecules.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands
$67.0M
raised

Alesta Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic.

Jan 2025
Series A

Founder Contacts

41,000+ verified contacts

Fort Lauderdale, United States
$100.0M
raised

Syncromune is a clinical stage biopharmaceutical dedicated to the development of better immunotherapies for metastatic solid tumors.

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$23.8M
raised

Unlocking home medication with pharma grade storage compliance as a service

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$11.7M
raised

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

Dec 2024
Series A

Founder Contacts

41,000+ verified contacts

Showing 276 to 300 of 774 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 774 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

774 Biotechnology Series A Startups (November 2026) — Page 12 | VCBacked